Top Markets
Coin of the day
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Classificação em ações #33959
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Preço da ação
$17.15
Última sincronização: 2026-08-03
Valor de mercado
$6.51M
Variação (1 dia)
9.80%
Variação (1 ano)
289.77%
País
US
Negociar Galera Therapeutics, Inc. (GRTX)

Categoria

Histórico de desdobramentos de ações de Galera Therapeutics, Inc. (GRTX)
As ações Galera Therapeutics, Inc. (símbolo: GRTX) passaram por um total de 1 desdobramentos.
O desdobramento mais recente ocorreu em Jul 13, 2026.
Uma ação GRTX comprada antes de Jul 13, 2026 equivaleria hoje a 0.005 ações GRTX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2026-07-13 1:200 x0.005 x0.005
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE